Ligand validation:7TOL

MET: METHIONINE

MET is a Ligand Of Interest in 7TOL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7TOL_MET_A_606	68%	42%	0.123	0.933	0.87	1.35	1	2	0	0	100%	0.91
7TOM_MET_A_606	93%	34%	0.083	0.979	1.05	1.55	1	2	0	0	100%	0.87
5HR6_MET_B_501	100%	56%	0.033	0.996	1.07	0.62	-	-	2	0	100%	1
3TQW_MET_A_238	100%	46%	0.039	0.992	0.87	1.2	1	1	1	0	100%	1
5EXK_MET_C_404	100%	37%	0.039	0.987	0.93	1.52	1	1	0	0	100%	1
3AYL_MET_A_905	99%	42%	0.048	0.984	1.31	0.94	1	-	1	0	100%	1
4QYM_MET_A_501	99%	47%	0.051	0.984	0.87	1.16	1	1	1	0	100%	0.77

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.